drugset / Trial / NCT03315910

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

NCT03315910

RandomizedFactorialOpen-labelPrevention

Summary

This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.

Timeline

Start
2017-10-10
Primary completion
2026-10
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg
Subject Nicotine Unknown 14 mg Other
Subject Nicotine Unknown 21 mg Other

Indications

No indication recorded.